Dashboard
Manage Tickers

INBX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

us-stocks-jump-to-records-amid-weak-inflation-investor-fear-eases-greed-index-remains-in-fear-zone
US Stocks Jump To Records Amid Weak Inflat...
10/27/2025 06:18:09

Stocks hit all-time highs as inflation eased, boosting confidence for Fed rate cut. Fear & Greed Index shows fear, but high...

stocks-soar-to-records-after-weak-inflation-ford-jumps-10-whats-moving-markets-friday
Stocks Soar To Records After Weak Inflatio...
10/24/2025 17:22:10

Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction th...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/24/2025 17:05:52

dow-jumps-over-500-points-us-consumer-sentiment-declines-in-october
Dow Jumps Over 500 Points; US Consumer Sen...
10/24/2025 16:17:09

ford-inhibrx-biosciences-comfort-systems-western-union-and-other-big-stocks-moving-higher-on-friday
Ford, Inhibrx Biosciences, Comfort Systems...
10/24/2025 14:33:59

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/24/2025 12:07:33

why-intel-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Intel Shares Are Trading Higher By Aro...
10/24/2025 09:25:15

why-are-inhibrx-biosciences-shares-soaring-76-after-hours
Why Are Inhibrx Biosciences Shares Soaring...
10/24/2025 07:05:02

Inhibrx Biosciences shares surged nearly 76% in after-hours trading Thursday after the company reported positive Phase 2 trial ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 21:06:21

inhibrx-biosciences-shares-resume
Inhibrx Biosciences Shares Resume
10/23/2025 20:44:45

trading-halt-halt-status-updated-at-42500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 4:25:...
10/23/2025 20:25:06

inhibrx-biosciences-reports-topline-results-from-registrational-chondragon-study-investigating-ozekibart-as-single-agent-vs-placebo-in-patients-with-unresectable-chondrosarcoma-ozekibart-meets-primary-endpoint-in-chondrosarcoma
Inhibrx Biosciences Reports Topline Result...
10/23/2025 20:20:25

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful imp...

trading-halt-halted-at-40010-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:00:10 p.m. ET - ...
10/23/2025 20:00:13

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 21:06:21

inhibrx-biosciences-to-webcast-chondragon-study-results-for-ozekibart-in-chondrosarcoma-on-october-23
Inhibrx Biosciences To Webcast ChonDRAgon ...
10/22/2025 20:02:53

– Event to be webcast live on Thursday, October 23, 2025 at 1:30 p.m. PT –SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- Inhibrx Bios...

jmp-securities-reiterates-market-perform-on-inhibrx-biosciencesto-market-perform
JMP Securities Reiterates Market Perform o...
08/22/2025 12:55:36

JMP Securities analyst Reni J. Benjamin reiterates Inhibrx Biosciences (NASDAQ:INBX) from Market Perform to Market Perform.

inhibrx-biosciences-q2-eps-185-beats-276-estimate-sales-1300m-up-from-100000k-yoy
Inhibrx Biosciences Q2 EPS $(1.85) Beats $...
08/13/2025 20:28:47

jmp-securities-reiterates-market-perform-on-inhibrx-biosciencesto-market-perform
JMP Securities Reiterates Market Perform o...
05/15/2025 14:02:22

JMP Securities analyst Reni Benjamin reiterates Inhibrx Biosciences (NASDAQ:INBX) from Market Perform to Market Perform.

inhibrx-q1-eps-280-beats-284-estimate
Inhibrx Q1 EPS $(2.80) Beats $(2.84) Estimate
05/14/2025 20:25:23

Inhibrx (NASDAQ:INBX) reported quarterly losses of $(2.80) per share which beat the analyst consensus estimate of $(2.84) by 1....

inhibrx-biosciences-announces-departure-of-dr-brendan-eckelman-co-founder-and-chief-scientific-officer-and-appoints-dr-carlos-bais-and-david-matly-to-cso-and-president-respectively
Inhibrx Biosciences Announces Departure Of...
04/01/2025 20:06:57

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION